| Datum |
Zeit |
Quelle |
Überschrift |
|---|
| 10.4.2024 | 15:00 | BW | Amylyx Pharmaceuticals Announces Interim Data From Ongoing.. |
| 09.4.2024 | 11:45 | PRNUS | The Gross Law Firm Notifies Amylyx Pharmaceuticals, Inc... |
| 08.4.2024 | 15:00 | BW | Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss.. |
| 05.4.2024 | 11:45 | PRNUS | Amylyx Pharmaceuticals, Inc. Sued for Securities Law.. |
| 04.4.2024 | 13:00 | BW | Amylyx Pharmaceuticals Announces Formal Intention to Remove.. |
| 02.4.2024 | 11:45 | PRNUS | The Gross Law Firm Reminds Amylyx Pharmaceuticals, Inc... |
| 29.3.2024 | 10:45 | PRNUS | The Gross Law Firm Announces the Filing of a Securities.. |
| 26.3.2024 | 10:45 | PRNUS | Shareholders of Amylyx Pharmaceuticals, Inc. Should Contact.. |
| 25.3.2024 | 13:00 | PRNUS | INVESTOR ALERT: AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX).. |
| 22.3.2024 | 10:45 | PRNUS | The Gross Law Firm Notifies Shareholders of Amylyx.. |
| 19.3.2024 | 10:45 | PRNUS | Amylyx Pharmaceuticals, Inc. Sued for Securities Law.. |
| 14.3.2024 | 14:00 | BW | Amylyx Pharmaceuticals Appoints Bernhardt Zeiher, MD, FCCP,.. |
| 14.3.2024 | 10:50 | PRNUS | The Gross Law Firm Reminds Shareholders of a Lead Plaintiff.. |
| 11.3.2024 | 13:44 | EDGAR2 | Form SC 13G - Statement of acquisition of beneficial.. |
| 11.3.2024 | 10:50 | PRNUS | Amylyx Pharmaceuticals, Inc. Class Action: The Gross Law.. |
| 08.3.2024 | 13:10 | EDGAR2 | Form 8-K - Current report |
| 08.3.2024 | 13:00 | BW | Amylyx Pharmaceuticals Announces Topline Results From Global.. |
| 07.3.2024 | 22:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 07.3.2024 | 22:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 07.3.2024 | 22:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 07.3.2024 | 11:45 | PRNUS | Amylyx Pharmaceuticals, Inc. Sued for Securities Law.. |
| 29.2.2024 | 00:22 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 29.2.2024 | 00:20 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 29.2.2024 | 00:13 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 27.2.2024 | 23:59 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 26.2.2024 | 11:45 | PRNUS | AMLX LAWSUIT ALERT: The Gross Law Firm Notifies Amylyx.. |
| 23.2.2024 | 22:05 | BW | Amylyx Pharmaceuticals Announces Inducement Grants Under.. |
| 22.2.2024 | 22:29 | EDGAR2 | Form S-8 - Securities to be offered to employees in employee.. |
| 22.2.2024 | 14:22 | EDGAR2 | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 22.2.2024 | 13:08 | EDGAR2 | Form 8-K - Current report |
| 22.2.2024 | 13:00 | BW | Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year.. |
| 22.2.2024 | 11:45 | PRNUS | Amylyx Pharmaceuticals, Inc. Class Action: The Gross Law.. |
| 15.2.2024 | 22:05 | BW | Amylyx Pharmaceuticals to Report Fourth Quarter and Full.. |
| 15.2.2024 | 15:00 | BW | Amylyx Pharmaceuticals to Present Updates on its AMX0114 and.. |
| 15.2.2024 | 11:00 | PRNUS | Lost Money on Amylyx Pharmaceuticals, Inc.(AMLX)? Join Class.. |
| 08.2.2024 | 15:00 | BW | Amylyx Pharmaceuticals Announces Completion of Enrollment in.. |
| 11.1.2024 | 23:11 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 11.1.2024 | 23:10 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 29.12.2023 | 22:07 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 22.12.2023 | 15:00 | BW | Amylyx Pharmaceuticals Announces First Participant Dosed in.. |
| 19.12.2023 | 22:37 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 07.12.2023 | 13:00 | EDGAR2 | Form 8-K - Current report |
| 04.12.2023 | 15:00 | BW | Amylyx Pharmaceuticals Announces Publication of Data Showing.. |
| 29.11.2023 | 23:15 | BW | Amylyx Pharmaceuticals Announces Inducement Grants Under.. |
| 28.11.2023 | 13:00 | BW | Amylyx Pharmaceuticals Appoints Camille L. Bedrosian, MD, as.. |
| 27.11.2023 | 15:00 | BW | RELYVRIO® and AMX0114 Data to be Presented at 34th.. |
| 21.11.2023 | 15:00 | BW | Amylyx Pharmaceuticals to Participate at the 6th Annual.. |
| 21.11.2023 | 02:20 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 09.11.2023 | 13:07 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 09.11.2023 | 13:00 | BW | Amylyx Pharmaceuticals Reports Third Quarter 2023 Financial.. |
Hot Features
Premium
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
